Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum]

This article refers to:

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection

LeVee A, Lin CY, Posadas E, et al. Onco Targets Ther. 2021;14:4819–4832.

The authors have advised there is an error in the author list on page 4819. The author name “Charlos J Rosser” should read “Charles Joel Rosser”.